Identifying markers of COVID-19 infection using blood tests

December 04, 2020

Researchers from the Institute of Biomedicine of Seville (IBIS) have presented a study carried out in the Clinical Biochemistry Service of the Virgen del Rocío University Hospital which identifies the values for six biochemical biomarkers that indicate a patient may be infected with SARS-COV-2 (COVID-19). The key novelty of this study, led by Dr. Juan Miguel Guerrero, head of service and IR of the IBiS Molecular NeuroImmunoendocrinology group, lies in the fact that it was carried out using a blood test and can provide a determination in about 60 minutes.

The Coronavirus continues to concern society and occupy researchers and health professionals. Research remains key to achieving not only a vaccine but also a rapid diagnosis of the disease. The Laboratory of the Virgen del Rocío University Hospital in Seville has identified the values of six biochemical biomarkers which indicate the patient may be infected with the Coronavirus.

This was possible thanks to their cooperation with the specialists at the Clinical Biochemistry service, who evaluated the routine blood tests of more than 200 people conducted in the ED to detect infection. Specifically, they analysed the accuracy of each biomarker to differentiate between patients infected with COVID-19 and those who aren't. The researchers behind the study have established six criteria linked to suspected COVID-19 infection using the blood lymphocyte and eosinophil count, and the levels of ferritin, lactate dehydrogenase, C-reactive protein and d-dimer in plasma. Ninety-one percent of patients infected with COVID-19 met one or more of these biomarker criteria. It is thus possible to rule out a Coronavirus infection with a high degree of probability in patients who meet none of these criteria.

All hospitals have the facilities to test for these biomarkers using quick, automated analysers (in less than 60 minutes). These laboratory criteria, combined with medical history and imaging tests, can be very useful to screen patients with suspected COVID-19.

For this study, the researchers collaborated with the company Blueberry Diagnostics, creating an algorithm that uses artificial intelligence to identify patients infected with COVID-19 with a sensitivity of 100% and a specificity of 100%. A second algorithm has been developed that can detect those patients with a more serious prognosis from the disease, thus making it possible to prioritise their treatment and reduce the mortality rate. The algorithms have since been turned into decision trees which are to be released through a public license so that any hospital can analyse them in its own laboratory.
-end-


University of Seville

Related Biomarkers Articles from Brightsurf:

Urgent need for blood-based biomarkers to diagnosis concussion
There is an urgent need for objective markers for diagnosing concussion, or mild traumatic brain injury.

Engineered bacteria churn out cancer biomarkers
A Cornell lab has created these very tools by commandeering simple, single-celled microorganisms - namely E. coli bacteria - and engineering them to explore the complex process of glycosylation and the functional role that protein-linked glycans play in health and disease.

Exercise induces secretion of biomarkers into sweat
The aim was to reveal the potential of microRNAs in sweat extracellular vesicles in monitoring exercise performance.

Phosphoprotein biomarkers to guide cancer therapy are identified
Researchers led by James Bibb, Ph.D., professor of surgery at the University of Alabama at Birmingham, suggest using a broader lens of post-translational modification analysis to identify new biomarkers of cancer drivers that may allow a much more precise prediction of patient responses to treatments.

Exhaled biomarkers can reveal lung disease
Using specialized nanoparticles, MIT engineers have developed a way to diagnose pneumonia or other lung diseases by analyzing the breath exhaled by the patient.

Race-specific lupus nephritis biomarkers
A University of Houston biomedical researcher has discovered a difference in urinary biomarker proteins of lupus nephritis in patients according to race.

Semen miRNAs could be non-invasive biomarkers for prostate cancer
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr.

Scientists have found longevity biomarkers
An international group of scientists studied the effects of 17 different lifespan-extending interventions on gene activity in mice and discovered genetic biomarkers of longevity.

After concussion, biomarkers in the blood may help predict recovery time
A study of high school and college football players suggests that biomarkers in the blood may have potential use in identifying which players are more likely to need a longer recovery time after concussion, according to a study published in the July 3, 2019, online issue of Neurology, the medical journal of the American Academy of Neurology.

3D-printed device detects biomarkers of preterm birth
Preterm birth (PTB) -- defined as birth before the 37th week of gestation -- is the leading complication of pregnancy.

Read More: Biomarkers News and Biomarkers Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.